← Back to company shares
IR
Ironclad Ventures
IRVE · BiotechnologyApplied biotechnology research aimed at treating chronic and rare conditions. Backed by Ironclad Ventures's operating track record in the biotechnology space.
Price / Share
$549.2
Shares Sold
77,269 / 550,000
Shares Remaining
472,731
14% subscribed
Log in to purchase shares